Resources & Articles
Test Updates
- CRP or hs-CRP
- October 1, 2010 by Barry P. Latner, M.D., Medical Director of Laboratory Services
- Although Shakespeare did not have this question in mind when he wrote Hamlet, it is an appropriate one to consider when completing a laboratory test requisition. C-reactive protein (CRP) is one of the most sensitive acute phase proteins and appears to be a nonspecific host defense against inflammation... more...
- Test Change Announcement
- July 1, 2010 by MuirLab
- Effective August 4, 2010 the name of the test "UA conditional" (15015) will be changing. The test will now be named UA with Microscopic (C&S if indicated). When this test is ordered, a complete urinalysis is performed which includes... more...
- Norovirus Outbreak Specimens
- July 1, 2010 by MuirLab
- Outbreak Norovirus specimens are processed at California State Public Health laboratories. They are currently charging for this service. In the event of a facility or regional outbreak, State laboratories are prepared to process specimens rapidly and are able to track the progress of outbreaks throughout the State. If a Norovirus Outbreak is suspected,... more...
- Introduction of Blood Testing for TB: Interferon-Gamma Release Assay
- April 1, 2010 by Barry P. Latner, M.D., Medical Director
- Tuberculosis remains a contemporary disease. Since 1993, the proportion of cases in the United States has increased each year in foreign-born vs. U.S. born individuals. By 2007, the TB rate among immigrants was 9.7 times higher than in U.S.-born citizens... more...
- Novel Influenza A (H1N1) - Laboratory Perspective
- June 30, 2009 by Barry Latner, M.D., Medical Director Laboratory Services, John Muir Health
- At the time of this writing, the World Health Organization (WHO) has changed the phase of pandemic alert for the novel Influenza A (H1N1) virus from Phase 5 to Phase 6. This indicates a global pandemic is underway in which there is little or no immunity in the population. While the upgrade designation is... more...
- Allergy News
- June 30, 2009 by MuirLab
- Allergy and diseases caused or complicated by allergy, such as asthma, or diseases with symptoms which mimic allergy, are among the most widespread and costly health problems in the world. John Muir Health, MuirLab will soon provide testing for allergy that is safe, simple, and accurate with groundbreaking technology with the latest generation... more...
- High Risk Human Papilloma Virus (HPV)
- May 1, 2009 by MuirLab
- Beginning May 1, 2009 MuirLab changed its method of high risk HPV to a newly FDA-approved molecular methodology from Hologic, Inc. While we have been very satisfied with the performance of our previous assay, market forces have eliminated that manufacturer from the HPV cytology product line more...
- Introduction of HIV-1 Viral Load Testing by PCR at MuirLab
- October 1, 2008 by MuirLab
- In our continuing commitment to provide innovative laboratory services for patients and physicians, John Muir Health and MuirLab are pleased to offer the next evolution in HIV-1 viral load testing, the COBAS® AmliPrep/Taqman HIV-1 test by Roche Diagnostics. This FDA-approved real time... more...
- Estradiol Assay Update
- October 1, 2008 by Barry P. Latner, M.D. Medical Director, Laboratory Services
- The manufacturer of our Estradiol assay has updated its standardization to the international reference method of isotope dilution gas chromatography mass spectrometry (ID-GCMS) method from the USP reference material. As a result, there are some changes... more...
- Stat Gram Stain Specimens
- May 1, 2008 by MuirLab
- On March 31, 2008, the Microbiology Department will be moving to the new MuirLab Core Lab in Concord. In order to expedite STAT gram stains on specimens that will need to be read in the hospital, we are requesting that two swabs of the specimen be submitted to the Laboratory. One swab will be used to make the gram stain and the second... more...
- Creatinine: Introduction of updated method calibrated to be traceable to IDMS
- May 1, 2008 by Barry P. Latner, M.D., Medical Director, Laboratory Services
- In 2004 the clinical laboratories of John Muir Health started reporting estimated glomerular filtration rate (eGFR) along with serum/plasma creatinine as recommended by the National Kidney Foundation. The rationale for this was to remind us that approximately 11% of the U.S. adult population has chronic kidney disease,... more...
- Change in Reflex Criteria for Urine Culture
- May 1, 2008 by Nader Shihabi, MD and Bernard Larner, MD
- We are changing the criteria for reflex urine cultures. In the past, the only criteria for urine cultures was WBC >10 in the urine. We will now also culture urines with positive leukocyte esterase or positive nitrite. These two parameters were... more...
- CBC with Auto Differential & CBC with Manual Differential
- April 1, 2008 by MuirLab
- Effective April 1, 2008, "CBC with Auto Differential" and "CBC with Manual Differential" will be combined into a single test, "CBC with Differential". Automated or manual differential results will be reported based upon internal laboratory reflex criteria. If specific morphologic evaluation... more...
- Update to Cardiac Troponin I (cTnI) Reporting
- January 1, 2008 by Barry P. Latner, M.D., Medical Director, Laboratory Services, John Muir Health
- In September (2007) the Clinical Laboratories of John Muir Health introduced a new assay for cTnI and implemented reporting practice guidelines published in the laboratory literature and endorsed by all major cardiology organizations (including ACC and AHA). A significant guideline for cTnI was the decision-limit for myocardial injury/myocardial-cell necrosis being set at the 99th percentile of a population of normal, healthy individuals... more...
- Encourage HIV/Aids Testing
- January 1, 2008 by MuirLab
- Despite recent improved access to antiretroviral treatment and care in many regions of the world, the AIDS pandemic claimed between 2.4 and 3.3 million lives in 2005, the highest number since 1981. Half a million or more than 570,000 of these deaths were children less than 15 years old... more...
- Diagnosing Legionnaire's Disease: Legionella Detection by PCR
- January 1, 2008 by MuirLab
- The genus Legionella includes over 40 different species of fastidious Gram-negative bacilli. While these organisms represent normal environmental flora, many have been shown to cause human disease, most commonly opportunistic pneumonia in immunocompromised patients. The vast majority of such cases... more...
- Reporting of Phenytoin (Dilantin) Concentration
- July 1, 2007 by Barry Latner, MD
- In an attempt to remind clinicians of the importance of the degree of protein binding in the action of phenytoin and in the interpretation of serum/plasma phenytoin concentrations, the Clinical Laboratories of John Muir Health will soon report... more...
- PLAC® Test
- July 1, 2007 by MuirLab
- The PLAC test is a blood test that measures the level of Lp-PLA2, an enzyme highly specific for vascular inflammation and implicated in the formation of rupture-prone plaque. The PLAC test is cleared by the FDA to aid in assessing risk of both coronary heart disease and ischemic stroke associated... more...
- Diagnosis of Enterohemorrhagic E. coli infection by Detection of Shiga Toxin
- July 1, 2007 by MuirLab
- Enterohemorrhagic E. coli (EHEC), also known as Shiga-toxin-producing E. coli (STEC), is recognized as an important cause of human diarrhea, hemorrhagic colitis, thrombotic thrombocytopenic purpura (TTP) and hemolytic uremic syndrome (HUS). The E. coli serotype O157:H7 has been documented as the most common... more...
- Chemistry and Immunochemistry Instrumentation/New Reference Ranges
- July 1, 2007 by MuirLab
- Beginning September 11, 2007 the Clinical Laboratories of John Muir Health will complete the conversion of all of its chemistry and immunochemistry assays (> 70 tests) to a single new platform. This change to Beckman Coulter instrumentation is made... more...